Species: Parvimonas sp. HMT-110 (HMT-0110) Primary Body Site: Oral
Download Options
LINKS: Ecology Home
| HMT-0110: [Body Sites Data]
[Taxon Description]
| Life Page: Parvimonas sp. HMT-110
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.29 | 0.03 | 0.06 | 0.04 | 0.01 | 0 | 0.03 | 0.02 | 0.11 | 0.05 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.01 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.01 | 0 | 0.01 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 |
| 90thp | 0.59 | 0.08 | 0.12 | 0.10 | 0.02 | 0 | 0.04 | 0.04 | 0.34 | 0.13 | 0 | 0 | 0 | 0.01 | 0 | 0 | 0.01 | 0 |
| Stdev | 0.35 | 0.05 | 0.10 | 0.11 | 0.01 | 0 | 0.01 | 0.02 | 0.19 | 0.09 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0.02 | 0 |
| Prev(%) | 75.00 | 21.52 | 16.67 | 13.33 | 0.31 | 0 | 0 | 14.29 | 13.64 | 29.31 | 1.54 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to P. micra and P. sp. HMT 110 were assigned half to each taxon
reads equally close to P. micra and P. sp. HMT 110 were assigned half to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.05 | 0.01 | 0 | 0.01 | 0.03 | 0.02 | 0.03 | 0.07 | 0.04 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.16 | 0.03 | 0 | 0.02 | 0.11 | 0.06 | 0.08 | 0.16 | 0.11 | 0 |
| Stdev | 0.09 | 0.02 | 0 | 0.01 | 0.06 | 0.05 | 0.10 | 0.18 | 0.07 | 0 |
| Prev(%) | 54.55 | 28.57 | 7.79 | 23.38 | 50.65 | 38.96 | 44.16 | 51.95 | 40.26 | 0 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to P. micra, P. sp. HMT 110, and P. sp. HMT 393 were assigned one-third to each taxon.
Reads equally close to P. micra, P. sp. HMT 110, and P. sp. HMT 393 were assigned one-third to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.20 | 0.05 | 0.01 | 0.02 | 0.08 | 0.06 | 0.07 | 0.14 | 0.06 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.50 | 0.12 | 0.01 | 0.06 | 0.22 | 0.15 | 0.17 | 0.31 | 0.17 | 0 |
| Stdev | 0.23 | 0.07 | 0.04 | 0.04 | 0.13 | 0.07 | 0.16 | 0.27 | 0.11 | 0 |
| Prev(%) | 87.84 | 68.92 | 13.51 | 55.41 | 68.24 | 75.68 | 72.30 | 80.41 | 56.76 | 2.10 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.18 | 0.03 | 0 | 0 | 0 | 0 | 0.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.61 | 0.07 | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0.34 | 0.07 | 0 | 0 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 58.28 | 41.72 | 0 | 0 | 0 | 0 | 11.90 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
HMTs 110-111-393 were not present singularly so these reads were split evenly at these sites (BMU,HPA,SAL,SUPP,TDO)
HMTs 110-111-393 were not present singularly so these reads were split evenly at these sites (BMU,HPA,SAL,SUPP,TDO)
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0 | 0.04 | 0 | 0.03 | 0.11 | 0.07 | 0 | 0 | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0 | 0.11 | 0 | 0.07 | 0.36 | 0.19 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stdev | 0 | 0.07 | 0 | 0.07 | 0.20 | 0.11 | 0 | 0 | 0.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Prev(%) | 0 | 61.95 | 0 | 47.89 | 61.38 | 70.24 | 0 | 0 | 58.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
No Notes
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.71 | 0.10 | 0.09 | 0.03 | 0.09 | 0.18 | 0.04 | 0.04 | 0.07 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 3.31 | 0.20 | 0.32 | 0.07 | 0.16 | 0.42 | 0.12 | 0.15 | 0.23 | 0 |
| Stdev | 1.54 | 0.20 | 0.20 | 0.04 | 0.22 | 0.35 | 0.06 | 0.06 | 0.12 | 0 |
| Prev(%) | 79.73 | 79.41 | 62.79 | 65.71 | 82.14 | 84.00 | 81.82 | 87.10 | 62.50 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
